The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Uniflu with Vitamin C Tablets

Phoenix LabsPA1113/005/001

Main Information

Trade NameUniflu with Vitamin C Tablets
Active SubstancesCaffeine
Diphenhydramine hydrochloride
Phenylephrine hydrochloride
Ascorbic acid
Dosage FormFilm-coated tablet + tablet
Licence HolderPhoenix Labs
Licence NumberPA1113/005/001

Group Information

ATC CodeN02BE Anilides
N02BE51 paracetamol, combinations excl. psycholeptics


License statusAuthorised
Licence Issued01/04/1978
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicencePharmacy only: MAXIMUM PACK SIZE 24. Maximum two packs per sale. Promotion to the public: Pack size not more than 24
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back